Medworth Acquisition Corp (MWRX) 8.34 $MWRX
MergeWorthRx to terminate merger agreement with AeroCare on 29 December
M2 - Tue Dec 30, 4:32AM CST
MergeWorthRx Corp (Nasdaq:MWRX), a special purpose acquisition company, announced on Monday that its merger agreement with AeroCare Holdings Inc will be terminated on 29 December 2014.
MWRX: 8.34 (-0.02)
MergeWorthRx Corp. Announces Expected Termination of Merger Agreement With AeroCare and Planned Redemption of Publicly-Held Common Stock and Planned Subsequent Dissolution
GlobeNewswire - Mon Dec 29, 2:16PM CST
MergeWorthRx Corp. (Nasdaq:MWRX) (the "Company"

announced today that it expects the previously announced merger agreement with AeroCare Holdings, Inc. to be terminated today and that it plans to cease operations except for the purpose of winding up and redeeming, in accordance with its amended and restated certificate of incorporation, the shares of common stock of the Company issued in the Company's initial public offering. The effective date of the redemption is December 31, 2014. The per share amount expected to be paid to the Company's public stockholders on the effective date is $8.36. Payment of such amounts will constitute the Company's final payment in respect of the liquidation of the trust account that holds the proceeds of the Company's initial public offering. As promptly as possible following such redemption, MWRX will dissolve. Under MWRX's amended and restated certificate of incorporation, MWRX had until December 26, 2014 to either consummate a business combination or commence proceedings to liquidate the trust account and dissolve.
MWRX: 8.34 (-0.02)
MergeWorthRx Corp. Announces Offer by Its Sponsors to Transfer Founder Shares to Certain Investors
GlobeNewswire - Tue Dec 16, 9:33AM CST
MergeWorthRx Corp. (Nasdaq:MWRX) ("MWRX"

, a special purpose acquisition company focused on the U.S. healthcare services market, announced today that its sponsors are offering to transfer up to 800,000 shares of MWRX common stock to certain investors (the "Investors"

in exchange for either the purchase or retention by the Investors of up to 4,000,000 shares of MWRX common stock. It is currently anticipated that MWRX's sponsors will transfer to the Investors 0.2 shares of MWRX common stock for every share of MWRX common stock that is either purchased by the Investors in the open market or through privately negotiated transactions or retained by the Investors who are current stockholders and who do not exercise conversion rights in connection with the previously-announced stockholder vote to approve the business combination ("Business Combination"

between MWRX and AeroCare Holdings, Inc. ("AeroCare"

. The sponsors are offering to enter into such agreements in order to increase the likelihood that the closing conditions set forth in the merger agreement relating to the Business Combination are satisfied and the Business Combination is consummated.
MWRX: 8.34 (-0.02)
MergeWorthRx Corp. Announces Record and Meeting Dates for Special Meeting Relating to Previously Announced Proposed Business Combination With AeroCare Holdings, Inc.
GlobeNewswire - Wed Dec 03, 4:41PM CST
MergeWorthRx Corp. (Nasdaq:MWRX) (the "Company"

announced today that it has set a record date of December 9, 2014 and a meeting date of December 22, 2014 for the special meeting in lieu of the 2014 annual meeting of stockholders of the Company (the "Special Meeting"

relating to the previously announced proposed business combination (the "Business Combination"

between the Company and AeroCare Holdings, Inc. ("AeroCare"

. Stockholders of record as of December 9, 2014 will be invited to attend the Special Meeting to consider and vote upon a proposal to approve and adopt the previously announced Agreement and Plan of Merger and Reorganization, dated as of October 14, 2014, as it may be amended (the "Merger Agreement"

, by and among the Company, Anvil Merger Sub, Inc., a Delaware corporation, AeroCare and FFC Aerocare SR, LLC, a Delaware limited liability company, and the transactions contemplated thereby, as well as to consider and vote upon related matters. Only holders of record of the Company's common stock at the close of business on December 9, 2014 are entitled to notice of the special meeting of stockholders and to vote and have their votes counted at the special meeting and any adjournments or postponements of the special meeting of stockholders.
MWRX: 8.34 (-0.02)
MergeWorthRx Corp. and AeroCare Holdings, Inc. to Present at Oppenheimer 25th Annual Healthcare Conference December 10-11, 2014 in New York
GlobeNewswire - Mon Nov 17, 7:19AM CST
MergeWorthRx Corp. (Nasdaq:MWRX), a special purpose acquisition company focused on the U.S. healthcare services market, and privately-held AeroCare Holdings, Inc. (AeroCare), a national leader in home respiratory therapy services, announced today that Steve Griggs, Founder, Chairman & CEO of AeroCare and Charles Fistel, CEO of MergeWorthRx Corp., are scheduled to present at the Oppenheimer 25 Annual Healthcare Conference in New York on Wednesday, December 10, 2014 at 1:00 p.m. EST. AeroCare and MergeWorthRx Corp. management will also be available for both days of the conference for private meetings. MergeWorthRx Corp. previously announced its proposed merger with AeroCare on October 15, 2014 (see link below).
MWRX: 8.34 (-0.02)
Healthcare-focused SPAC MergeWorthRx Acquires PE-backed AeroCare
at The Street - Thu Oct 16, 8:19AM CDT
AeroCare had been held by MTS Healthcare Partners LP and Ferrer, Freeman & Co. LLC since 2002.
MWRX: 8.34 (-0.02)
MergeWorthRx Corp. and AeroCare Holdings, Inc. Announce Definitive Agreement to Merge
GlobeNewswire - Wed Oct 15, 6:00AM CDT
MergeWorthRx Corp. (Nasdaq:MWRX), a special purpose acquisition company focused on the U.S. healthcare services market, and privately-held AeroCare Holdings, Inc. (AeroCare), a national leader in home respiratory therapy services with annual revenue of approximately $150 million, announced today that they have signed a definitive merger agreement pursuant to which AeroCare will become a publicly traded company through an all-stock merger with MergeWorthRx. The transaction, when consummated, will provide the post-merger company with additional capital as well as public company currency to enhance and expand its organic growth initiatives and for future strategic transactions.
MWRX: 8.34 (-0.02)